Biotech billionaire Dietmar Hopp digs deeper to back one of the drug developers in his portfolio

Biotech billionaire Dietmar Hopp is opening up the cash vault to help out one of his biotech startups.

Operating through dievini Hopp BioTech holding, Hopp has sunk a little more than $40 million into Heidelberg Pharma. The money can be put to use on the Phase I/II clinical program for…